EMA has recommended granting a marketing authorisation in the European Union (EU) for mCombriax, a messenger RNA vaccine for protecting people aged 50 years and older against COVID-19 and seasonal in… [+3983 chars]Read More
First combined COVID19 and influenza vaccine for people 50 years and older European Medicines Agency
